CrossrefInfokarte
Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study
Comprehensive Psychiatry · 2025-10 · 142 · 152619
DOI: 10.1016/j.comppsych.2025.152619 ↗Abstract
Kein Abstract verfügbar.
EUVIMED